[Various aspects of the medical treatment of newborn infants with heart disease].
Some aspects of the medical treatment of newborns with congenital heart disease. The outcome of new-born babies with critical congenital heart disease has dramatically improved over the last 25 years. Better understanding of the abnormal hemodynamic situations and thus more appropriate intensive care decisions, increased accuracy of the diagnosis obtained by color-doppler and echocardiography and improved surgical and anesthetic skills and technics, are the main factors of these better results. The authors describe the benefits of prostaglandin infusion in situations where anatomic anomalies prevent the parallel foetal circulation to change into a serial circulation system: severe stenosis or atresia of right or left cardiac valves, transposition of great vessels. Another example of improved medical treatment concerns balloon valvuloplasty. This new technic offers a valuable alternative to surgery in cases of severe isolated stenosis of aortic or pulmonary valves in the neonatal period.
Vliers
A
A
Jaumin
P
P
D002404:Catheterization; D015232:Dinoprostone / Q000627:therapeutic use*; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy; D006330:Heart Defects, Congenital / Q000628:therapy*; D006349:Heart Valve Diseases / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn
D015232:Dinoprostone
Quelques aspects du traitement médical des nouveau-nés cardiaques.